2 Cannabis Companies With Huge Potential That You May Have Never Heard of

Up until now, the major cannabis companies that have gotten the headlines have been large licensed producers that were expected to dominate the market. Unfortunately, that hasn’t panned out yet, as the government is slow to implement the legalization of cannabis fully.

From the government’s point of view, this move is prudent, as the government wants to make sure it gets it right and does it properly, since the legalization of cannabis is so important.

From the views of the producers and investors, though, this can be aggravating, as it takes much longer to reach profitability then was once expected.

There are, however, new opportunities in the cannabis space — ones that offer a much faster chance to profitability.

These smaller, more unknown companies are top-quality cannabis producers that have plans with potential for high growth, especially as edibles and extracts are legalized. The two companies are VIVO Cannabis (TSXV:VIVO) and WeedMD (TSXV:WMD).

VIVO Cannabis

VIVO is a small-cap Canadian cannabis company that is known for carefully curating its medical and recreation cannabis to get unmatched quality. It has won numerous awards for its high-quality bud and continues to learn as it tries new things and experiments with new products.

The company has been focusing on international markets for expansion, specifically Europe and Australia. Both are great to expand to since they seem to be quite ahead of the industry curve in regard to importing medical cannabis. The company has already begun selling in Australia and it’s awaiting its final licences from the European Union.

It has a number of brands all with the shared goal of creating the highest-quality cannabis. The brands are important because they help VIVO to target specific consumers. Its Lumina and Fire Side brands, for example, are used to target the adult recreational market in Canada.

VIVO also understands the advantages of leveraging these brands, as premium products and brand differentiation are the top ways to achieve higher prices and margins in such a commoditized industry.

On the production front, VIVO’s seasonal greenhouse design is a great way for the company to improve margins. The greenhouse is said to be a high-capacity, low-cost production facility. It helps improve margins, since it’s lower cost than growing indoor, but higher quality than growing outdoor.

With a market cap of just over $130 million, VIVO is one of the cheapest producers you can buy that also offers huge opportunity.

WeedMD

WeedMD is a vertically integrated cannabis company headquartered in Ontario. The company is focused on growing shareholder value through top-notch execution. It wants to execute by having impressive innovation to create new products and new customer experiences, as well as growing high-quality cannabis in a process that is scalable.

It expects to have nearly 150,000 kg of annual capacity by 2020. It’s also scaling to have 200,000 kg of extraction capacity. So far, the company has six agreements with provincial distributors.

WeedMD, which is also the name of its medical brand, has been building its number of  patients rapidly. It continues to find avenues for growth, signing a deal to supply Shoppers Drug Mart — one of the only licensed producers to do so. In addition, it’s the only medical cannabis brand to establish supply agreements with long-term-care providers.

The company has been rapidly advancing its next stage of products. Gel capsules are now being sold under the WeedMD brand. The company’s recreational brand Color Cannabis has also been getting ready to sell its pre-rolled joints and is preparing to release its concentrates products and edibles when the market for that is legalized.

WeedMD has a market cap of just over $175 million; it’s worth slightly more than VIVO, but it has just as much potential for growth.

Bottom line

Both companies have been quietly growing their production and product numbers ahead of the second wave of cannabis legalization in Canada. Each has their own plan, but both plans are full of growth opportunities and have huge potential. If you’re looking for the next big investment in cannabis, look no further than these two.

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned.

Source: The Fool
2 Cannabis Companies With Huge Potential That You May Have Never Heard of
The Fool

The Motley Fool
Contributor for investorsnews.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts